Replies to post #256773 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Thanks Tuca. Not too bad but hate to see Lovaza doing better than V.

[dV1]

Thanks tucaman

[couldbebetter]

tucaman, Greatly appreciate your posting the numbers.
If it is accurate that new scrips for Vascepa are down
while the numbers for generic Lovaza and Lovaza are actually up,
that is a signal that something is horribly wrong!

Once again I'll opine that GIA is not the way to go.
The sooner that Vascepa is in the hands of BP the better.
Not just for those of us who own stock, but for those poor
souls who are obviously being given the generic crap instead
of pure EPA Vascepa. The FDA could care less and is feckless.
I hope JT cares about patients that are being fed a much inferior
product. How long must this idiocy go on!?!?

[Toddrobertking]

90k in the midst of COVID-19 ....interesting

But the Lovaza #’s - infuriate me

[KevGee59]

Thanks for the numbers tuc!

KG ;)

[rafunrafun]

Thanks, T.

I'm so confused. It's as if the shutdown of the country doesn't effect the script?! Shocked that we are above 80k.

If our scripts aren't effected and it's our only product, why is the PPS effected?

[NickHous]

Wow 90,000 thanx tucaman

[irc203]

Thanks Tuc

[dukesking]

Tucaman, Thanks for supplying the scripts numbers. I’m happy that our scripts have risen over past two weeks but could you imagine where scripts would be if GL wasn’t infringing on ReduceIt results. I’m curious how many of the GL scripts are written by doctors for the ReduceIt benefits ( ignorantly)versus changed at the pharmacy as a cheaper substitute( incorrectly) at the pharmacy. Thanks again.

[MNBioMike]

Thx. More hoarding as more US states issue SIP orders. NRx will continue to fall off in Q2.

[Hondo1021]

Thanks Tuc. That's an ATH for total and refills. Woohoo!

[Restingzebra]

Nice numbers. Thank you very, very much for providing this important service. Stay healthy.

[rafunrafun]

Scripts.

Nearly identical, no reason to investigate the tiny discrepancy.

TRX: 90,094 (+3.47% w/w, +71.91% y/y)

NRX: 42,075 (+0.06 w/w, +56.87% y/y)

Refills: 48,019 (+6.65% w/w, +87.67% y/y)

[tucaman]

Scripts for week ending 03/27/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Vascepa
TRx: 85'477 (-5.16%)
NRx: 39'517 (-6.08%)

Generic Lovaza
TRx: 62'750 (-6.69%)
NRx: 30'833 (-7.27%)

[tucaman]

Scripts for week ending 04/10/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Note: Relative changes are compared to week 04/03, which I did not post last week. Add another -3.5%/-6.5% for TRx/NRx (both Vascepa & Lovaza) for the change over the last two weeks.

Vascepa
TRx: 81'187 (-1.54%)
NRx: 35'351 (-4.26%)

Generic Lovaza
TRx: 59'917 (-2.18%)
NRx: 27'417 (-5.19%)

[tucaman]

Scripts for week ending 04/17/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Vascepa
TRx: 81'288 (+0.12%)
NRx: 34'813 (-1.52%)

Generic Lovaza
TRx: 59'750 (-0.28%)
NRx: 27'333 (-0.30%)